A Peer-Driven Intervention to Increase PrEP Uptake Among Minority MSM
Peer-driven Intervention Promoting PrEP Uptake Among African American and Hispanic/Latino MSM
2 other identifiers
interventional
98
1 country
1
Brief Summary
The objective of this study is to develop an effective peer-driven intervention (PDI) approach and assess its feasibility and efficacy on pre-exposure prophylaxis (PrEP) uptake among men who have sex with men.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv-infections
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2021
CompletedFirst Posted
Study publicly available on registry
December 17, 2021
CompletedStudy Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 23, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 23, 2024
CompletedResults Posted
Study results publicly available
May 19, 2026
CompletedMay 19, 2026
April 1, 2026
2.5 years
August 26, 2021
April 1, 2026
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pre-exposure Prophylaxis (PrEP) Uptake
Participant self-report of having initiated PrEP medication at any point between the baseline visit and the 6-month follow-up. Data represent the number of participants who provided a 'Yes' response to the assessment question: 'Have you started taking PrEP since your last visit?
0-6 months
Number of Participants With PrEP Persistence
The number of participants who remained on PrEP medication without a gap of more than 30 days throughout the 6-month study period, as reported during follow-up interviews.
0-6 months
Pre-exposure Prophylaxis (PrEP) Adherence
Participant adherence to the prescribed PrEP regimen over the 30 days prior to the 6-month follow-up visit, measured via self-report. Adherence was calculated based on the frequency of doses taken per week. Participants were considered adherent if they reported taking at least 4 pills per week, which is the threshold associated with high levels of protection against HIV acquisition.
30 days prior to 6-month follow-up visit
Study Arms (2)
PDI group
EXPERIMENTALIn this group, participants will receive education about HIV and pre-exposure prophylaxis (PrEP) and be referred to our study by peer educators. Referred participants will have free PrEP counseling and receive referrals if interested. We will follow up at three and six months and check participants' PrEP status.
Control group
NO INTERVENTIONIn the control group, participants do not receive any education from peers and will be directly recruited by research assistants from venues (e.g. gay bars, LGBTQ communities, LGBTQ events, and social media advertisements). Participants will receive PrEP counseling and referral if interested. We will follow up at three and six months and check participants' PrEP status.
Interventions
This peer-driven intervention (PDI), modified based on respondent-driven sampling (RDS) or snowball sampling, is a "chain referral" approach. Index peers will be purposefully selected to reflect the diversity of African American (AA) and Hispanic/Latino (H/L) men who have sex with men (MSM) and are required to take a formal training about pre-exposure prophylaxis (PrEP) and HIV. These index peers will educate members of their social networks and encourage them to initiate PrEP. Those referred peers will schedule an appointment to complete a short survey and will be referred to our PrEP clinic if they are interested in PrEP uptake. The referred peers will serve as index peers for the following wave of recruitment. It is expected to achieve a robust sample of AA and H/L within six waves of recruitment. This PDI approach is potential to engage AA and H/L who are most at risk of HIV acquisition in PrEP uptake and could contribute to reducing the concentrated HIV epidemic.
Eligibility Criteria
You may qualify if:
- To be eligible for this study, participants must meet the following requirements:
- Age: 18 years of age or older. Gender/Sex: Assigned male at birth and currently identify as male. Sexual Orientation/Behavior: Having sex with men in the past three months. PrEP Status: Not currently on PrEP (Pre-Exposure Prophylaxis). Language: English- or Spanish-speaking.
You may not qualify if:
- Individuals meeting any of the following will be excluded:
- Age: Less than 18 years of age. Sexual Behavior: No history of having sex with men in the past three months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institute of Mental Health (NIMH)collaborator
- The Miriam Hospitallead
Study Sites (1)
The Miriam Hospital
Providence, Rhode Island, 02906, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Limitations include a small sample size and non-randomized design, which may limit the generalizability of findings and the ability to establish definitive causality. The study relied on self-reported data for PrEP initiation and adherence, which is subject to social desirability bias. Additionally, the short 6-month follow-up period may not capture long-term PrEP persistence. Most participants were recruited in one geographic area, potentially limiting broader applicability.
Results Point of Contact
- Title
- Jun Tao
- Organization
- The Miriam Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Jun Tao
The Miriam Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- No mask
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2021
First Posted
December 17, 2021
Study Start
July 1, 2022
Primary Completion
December 23, 2024
Study Completion
December 23, 2024
Last Updated
May 19, 2026
Results First Posted
May 19, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
We do not plan to share individual participant data due to confidentiality considerations and the sensitive nature of behavioral and HIV-related information collected.